Point of Care Diagnostics Market Size Worth $24.1 Billion by 2027 | CAGR: 3.2%: Grand View Research, Inc.
Key suggestions from the report:
- Glucose testing accounted for the largest revenue share owing to the high incidence rate of diabetes and the abundant usage of portable glucose meters
- Cancer markers are expected to witness the fastest growth rate due to the extensive ongoing R&D activities related to cancer and growing demand for circulating tumor cells (CTC) - based cancer detection
- POC tests offer several benefits as compared to conventional lab tests that lead to their high utilization rate in clinics, resulting in the largest revenue share of clinics
- These benefits include reduced turnaround testing timeline, delivery of on-site results, minimal contact with clinical staff, and faster diagnosis
- Continuous development of point of care devices, especially glucose meters, for home care settings, early detection, and prevention of diseases is expected to drive the home segment at the fastest growth rate
North America dominated the point of care testing market owing to the favorable government initiatives and programs related to lipid and blood sugar level testing that encourage the usage rate of point of care tests in this region- Key participants operating in this market include Danaher; Abbott Laboratories; bioMérieux SA;
Trividia Health, Inc. ; QIAGEN,F. Hoffmann-La Roche Ltd. ; and Siemens - Companies are adopting several strategic developments related to the development of biosensors for point of care settings
- For instance, in
September 2019 , BioMed X completed its collaboration withRoche Diagnostics for the development of nanomaterial-based biosensors for point of care testing
Read 250 page research report with ToC on "Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), By End Use (Clinics, Hospital),
These tests have emerged as an indispensable part of modern healthcare, as it improves the quality, accuracy, availability, and affordability of patient care. The uptake of POC devices is rapidly progressing due to the incorporation of advanced technologies. For instance, in
The growing popularity of rapid testing in near-patient settings has positively impacted point of care testing market growth. The rise in investments to develop advanced rapid testing devices, such as single integrated user-friendly devices, fuels market progression. For instance, in
- Point of Care Diagnostics/Testing Product Outlook (Revenue, USD Million, 2016 - 2027)
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Infectious Diseases
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and Drug-Resistant TB POC
- HSV POC
- Other Infectious Diseases
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug Abuse Testing
- Urinalysis
- Point of Care Diagnostics/Testing End-Use Outlook (Revenue, USD Million, 2016 - 2027)
- Clinics
- Physician Office
Pharmacy & Retail Clinics Non-practice Clinics Urgent Care Clinic - Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
- Point of Care Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America U.S. Canada Europe Germany France U.K. Italy Spain Russia Asia Pacific China Japan India Korea Australia Singapore Latin America Brazil Mexico Chile Argentina Middle East &Africa Saudi Arabia South Africa United Arab Emirates Nigeria Qatar Kenya Zimbabwe
Find more research reports on Clinical Diagnostics Industry, by
- Point-of-Care Molecular Diagnostics Market – The global point-of-care molecular diagnostics market size was valued at
USD 1.72 billion in 2018 and is anticipated to expand at a CAGR of 14.4% over the forecast period. - In Vitro Diagnostics Quality Control Market – The global
In Vitro Diagnostics quality control market size was valued atUSD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period. - Primary Care POC Diagnostics Market – The global primary care POC diagnostics market size was estimated at
USD 6.3 billion in 2016.Rapid evolution of point-of-care testing holds enormous potential for the growth of both primary and secondary care settings.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About
Contact:
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
View original content:http://www.prnewswire.com/news-releases/point-of-care-diagnostics-market-size-worth-24-1-billion-by-2027--cagr-3-2-grand-view-research-inc-301026642.html
SOURCE
Cape fund pivots to respond to COVID-19
Market value of Chattanooga firms plummets as coronavirus infects investor confidence
Advisor News
- When new investment trends emerge, Gen Z is most likely generation to be first in
- Could ‘plain English’ become an advisor’s secret weapon?
- IRI urges Senate action on 403(b) parity legislation
- Three estate planning ideas to protect your clients and their wealth
- What advisors must know about accessible client documents
More Advisor NewsAnnuity News
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
- Wink: Annuity sales post strong Q2, led by MYGAs and structured products
- Legacy Marketing Group partners with Malibu Life USA for annuity launch
More Annuity NewsHealth/Employee Benefits News
Life Insurance News